These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17991873)

  • 1. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-/- mice.
    van Leeuwen M; Gijbels MJ; Duijvestijn A; Smook M; van de Gaar MJ; Heeringa P; de Winther MP; Tervaert JW
    Arterioscler Thromb Vasc Biol; 2008 Jan; 28(1):84-9. PubMed ID: 17991873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophage-specific expression of mannose-binding lectin controls atherosclerosis in low-density lipoprotein receptor-deficient mice.
    Matthijsen RA; de Winther MP; Kuipers D; van der Made I; Weber C; Herias MV; Gijbels MJ; Buurman WA
    Circulation; 2009 Apr; 119(16):2188-95. PubMed ID: 19380618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis.
    Zernecke A; Bot I; Djalali-Talab Y; Shagdarsuren E; Bidzhekov K; Meiler S; Krohn R; Schober A; Sperandio M; Soehnlein O; Bornemann J; Tacke F; Biessen EA; Weber C
    Circ Res; 2008 Feb; 102(2):209-17. PubMed ID: 17991882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice.
    Nachtigal P; Pospisilova N; Jamborova G; Pospechova K; Solichova D; Andrys C; Zdansky P; Micuda S; Semecky V
    Life Sci; 2008 Mar; 82(13-14):708-17. PubMed ID: 18289605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of natural killer T cell activation on the initiation of atherosclerosis.
    van Puijvelde GH; van Wanrooij EJ; Hauer AD; de Vos P; van Berkel TJ; Kuiper J
    Thromb Haemost; 2009 Aug; 102(2):223-30. PubMed ID: 19652872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of experimental atherosclerosis.
    Jawień J; Nastałek P; Korbut R
    J Physiol Pharmacol; 2004 Sep; 55(3):503-17. PubMed ID: 15381823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of curcumin on atherosclerosis in apoE/LDLR-double knockout mice.
    Olszanecki R; Jawień J; Gajda M; Mateuszuk L; Gebska A; Korabiowska M; Chłopicki S; Korbut R
    J Physiol Pharmacol; 2005 Dec; 56(4):627-35. PubMed ID: 16391419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No effect of C-reactive protein on early atherosclerosis in LDLR-/- / human C-reactive protein transgenic mice.
    Torzewski M; Reifenberg K; Cheng F; Wiese E; Küpper I; Crain J; Lackner KJ; Bhakdi S
    Thromb Haemost; 2008 Jan; 99(1):196-201. PubMed ID: 18217154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice.
    Li D; Liu Y; Chen J; Velchala N; Amani F; Nemarkommula A; Chen K; Rayaz H; Zhang D; Liu H; Sinha AK; Romeo F; Hermonat PL; Mehta JL
    Biochem Biophys Res Commun; 2006 Jun; 344(3):701-7. PubMed ID: 16631603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies.
    van Leeuwen M; Damoiseaux J; Duijvestijn A; Heeringa P; Gijbels M; de Winther M; Tervaert JW
    Ann N Y Acad Sci; 2009 Sep; 1173():274-9. PubMed ID: 19758162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAGE mediates oxidized LDL-induced pro-inflammatory effects and atherosclerosis in non-diabetic LDL receptor-deficient mice.
    Sun L; Ishida T; Yasuda T; Kojima Y; Honjo T; Yamamoto Y; Yamamoto H; Ishibashi S; Hirata K; Hayashi Y
    Cardiovasc Res; 2009 May; 82(2):371-81. PubMed ID: 19176597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deficiency of the long pentraxin PTX3 promotes vascular inflammation and atherosclerosis.
    Norata GD; Marchesi P; Pulakazhi Venu VK; Pasqualini F; Anselmo A; Moalli F; Pizzitola I; Garlanda C; Mantovani A; Catapano AL
    Circulation; 2009 Aug; 120(8):699-708. PubMed ID: 19667236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LOX-1 deletion decreases collagen accumulation in atherosclerotic plaque in low-density lipoprotein receptor knockout mice fed a high-cholesterol diet.
    Hu C; Dandapat A; Sun L; Chen J; Marwali MR; Romeo F; Sawamura T; Mehta JL
    Cardiovasc Res; 2008 Jul; 79(2):287-93. PubMed ID: 18453637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic urotensin II infusion enhances macrophage foam cell formation and atherosclerosis in apolipoprotein E-knockout mice.
    Shiraishi Y; Watanabe T; Suguro T; Nagashima M; Kato R; Hongo S; Itabe H; Miyazaki A; Hirano T; Adachi M
    J Hypertens; 2008 Oct; 26(10):1955-65. PubMed ID: 18806619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
    Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
    Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adventitial fibroblasts are activated in the early stages of atherosclerosis in the apolipoprotein E knockout mouse.
    Xu F; Ji J; Li L; Chen R; Hu WC
    Biochem Biophys Res Commun; 2007 Jan; 352(3):681-8. PubMed ID: 17141183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
    Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
    Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice.
    Kato R; Mori C; Kitazato K; Arata S; Obama T; Mori M; Takahashi K; Aiuchi T; Takano T; Itabe H
    Arterioscler Thromb Vasc Biol; 2009 Jan; 29(1):33-9. PubMed ID: 18988894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerosis development in apolipoprotein E-null mice deficient for CD69.
    Gómez M; Sanz-González SM; Abu Nabah YN; Lamana A; Sánchez-Madrid F; Andrés V
    Cardiovasc Res; 2009 Jan; 81(1):197-205. PubMed ID: 18703531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
    Desai A; Zhao Y; Warren JS
    Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.